Results 91 to 100 of about 13,531,604 (176)

Regulation of Nicotinamide N-methyltransferase Expression in Adipocytes

, 2020
NNMT ist ein neuer Regler der Energiehomöostase. Seine Expression ist in Adipositas- und Diabetesmodellorgansimen erhöht. Ein verstärktes NNMT Level wird auch durch einen fettgewebs-spezifischen GLUT4 Knockout in Mäusen hervorgerufen, wobei die Überexpression des Glukosetransporters die NNMT Expression reduziert.
openaire   +2 more sources

Interferon-γ Elevates Nicotinamide N-Methyltransferase Activity and Nicotinamide Level in Human Glioma Cells

Journal of Nutritional Science and Vitaminology, 2010
Nicotinamide N-methyltransferase (NNMT) catalyzes the N-methylation of nicotinamide. NNMT is strongly expressed in tumor cells and an increase in NNMT activity may reduce cellular nicotinamide level and thereby promote cell survival in the cells. However, there has been no report of a relationship between NNMT activity and nicotinamide level in tumor ...
YAMADA, Kazuo, MIYAZAKI, Takeshi, HARA, Nobumasa, TSUCHIYA, Mikako   +3 more
openaire   +3 more sources

Neurodegenerative Diseases: Epidemiology, Risk Factors, Classification, Pathophysiology, Clinical Features, Diagnosis, and Therapeutic Strategies

MedComm, Volume 7, Issue 11, November 2026.
Neurodegenerative diseases share convergent risk architectures and pathological mechanisms, yet diverge in selective vulnerability, clinical presentation, and therapeutic responsiveness. This review integrates cross‐disease epidemiology, pathophysiology, diagnosis, and treatment, highlighting the transition from symptomatic care toward biomarker‐guided
Zimeng He, Jingjing Zeng, Guoqing Wang, Yuxin Li, Feng Zhang   +4 more
wiley   +1 more source

NNMT and the methylation sink: integrating metabolism, epigenetics and immunity in cancer

BMC Medicine
Nicotinamide N-methyltransferase (NNMT) is a methyltransferase that uses S-adenosyl-L-methionine (SAM, cofactor) to catalyze the N-methylation of nicotinamide (NAM, substrate), yielding 1-methylnicotinamide (MNAM) and S-adenosyl-homocysteine (SAH).
Lvyuan Li, Yichun Ma, Yani Pan, Bowen Li, Chen Chen, Qiang Wang, Yao Fu, Xiangshan Fan, Shouyu Wang, Zhangding Wang   +9 more
doaj   +1 more source

Gastric Cancer: Epidemiology, Risk Factors, Pathogenesis, Clinical Features, Diagnosis, and Management

MedComm, Volume 7, Issue 11, November 2026.
This comprehensive review summarizes gastric cancer epidemiology, multifactorial risk factors (like infectious, dietary, genetic), pathogenesis such as precancerous evolution, molecular alterations, and a focus on the bidirectional interactions between gastric cancer cells and macrophages in the tumor microenvironment.
Yixuan Xin, Xingya Wang, Yangtao Wu, Qian Liu, Qian Ren, Hui Wang, Jingbo Zhai   +6 more
wiley   +1 more source

Hydroxamic Acids as HDAC Inhibitor Drug Leads for Malaria

Medicinal Research Reviews, Volume 46, Issue 6, Page 1477-1498, November 2026.
ABSTRACT Malaria is a global health threat, with an estimated 282 million cases and 610,000 malaria‐associated deaths reported in 2024. Most mortality is due to infection by Plasmodium falciparum parasites, with the highest burden occurring in Sub‐Saharan Africa.
Wisam A. Dawood, Jacinta R. Macdonald, Christian Anzenhofer, Tina S. Skinner‐Adams, Robert C. Reid, Thomas Kurz, David P. Fairlie, Katherine T. Andrews   +7 more
wiley   +1 more source

Histone Modifications at the Intersection of Aging, Neuroinflammation and Metabolism in Alzheimer's Disease

Aging Cell, Volume 25, Issue 11, November 2026.
This review examines how histone modifications integrate aging, metabolic dysfunction and neuroinflammation to shape persistent, cell‐type‐specific chromatin states in Alzheimer's disease. By distinguishing causal regulation from association through perturbation, persistence and reversibility, it highlights metabolic–epigenetic feedback loops and ...
Junyi Liang, Huawen Cao, Xiumin Ren, Nan Sha, Xueqing Han, Ling Jiang, Bin Liu, Weiming Zhao   +7 more
wiley   +1 more source

Identification of nicotinamide N-methyltransferase as a novel tumor marker for renal cell carcinoma

, 2006
PURPOSE: To explore the involvement of enzymes of drug metabolism in renal cell carcinoma we analyzed the gene expression profiles of tumor and nontumor tissues from the same patient by DNA macroarray.
ROSSI V, MUZZONIGRO, GIOVANNI, MILANESE, Giulio, EMANUELLI, Monica, SARTINI, Davide, PIERELLA F   +5 more
core  

Histone deacetylase inhibitors as venetoclax‐sensitising partners in acute myeloid leukaemia: Mechanisms, pharmacology and translational perspectives

British Journal of Pharmacology, Volume 183, Issue 21, Page 6261-6290, November 2026.
Abstract Venetoclax combined with hypomethylating agents has improved treatment for older or unfit patients with acute myeloid leukaemia (AML), but resistance and relapse remain common. This review analyses the rationale for combining venetoclax with inhibitors of histone deacetylase (HDAC).
Jaebok Lee, Marc Diederich
wiley   +1 more source

Development of a Suicide Inhibition-Based Protein Labeling Strategy for Nicotinamide N-Methyltransferase [PDF]

, 2019
Nicotinamide N-methyltransferase (NNMT) catalyzes the S-adenosyl-l-methionine-dependent methylation of nicotinamide to form N-methylnicotinamide. This enzyme detoxifies xenobiotics and regulates NAD+ biosynthesis.
Zheng, Li, Weerapana, Eranthie, Salinger, Ari J., Thompson, Paul R, Fast, Walter, Mondal, Santanu, Sen, Sudeshna   +6 more
core   +1 more source